Assessment of Motor Function, Sensory Motor Gating and Recognition Memory in a Novel BACHD Transgenic Rat Model for Huntington Disease

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Abada, Yah se K ^a,b   Nguyen, Huu Phuc ^c   Schreiber, Rudy ^d   Ellenbroek, Bart ^e  

^a EVOTEC AG   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; COGNITIVE DEFECT; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; GAIT; HABITUATION; HUNTINGTON CHOREA; HYPERACTIVITY; MALE; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NONHUMAN; OPEN FIELD BEHAVIOR; PHENOTYPE; PREPULSE INHIBITION; RAT; RECOGNITION; ROTAROD TEST; SENSORY GATING; SENSORY MEMORY; STARTLE REFLEX; TASK PERFORMANCE; WILD TYPE;

ANIMALS; BEHAVIOR, ANIMAL; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; GAIT; GENOTYPE; HUMANS; HUNTINGTON DISEASE; MALE; MEMORY; MOTOR ACTIVITY; MUTATION; NERVE TISSUE PROTEINS; RATS; RATS, TRANSGENIC; RECOGNITION (PSYCHOLOGY); ROTAROD PERFORMANCE TEST; SENSORY GATING; STARTLE REACTION;

EID: 84880052149     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068584     Document Type: Article

References (58)

1. Douaud G, Gaura V, Ribeiro MJ, Lethimonnier F, Maroy R, et al. (2006) Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. NeuroImage 32(4):: 1562-1575. doi:10.1016/j.neuroimage.2006.05.057. PubMed: 16875847.
2. Jones L, Hughes A, (2011) Pathogenic mechanisms in Huntington's disease. Int Rev Neurobiol 98: 373-418. doi:10.1016/B978-0-12-381328-2.00015-8. PubMed: 21907095.
3. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, et al. (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44(6):: 559-577. doi:10.1097/00005072-198511000-00003. PubMed: 2932539.
4. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is unstable on Huntington's disease chromosomes. Cell 72: 971-983. doi:10.1016/0092-8674(93)90585-E. PubMed: 8458085.
5. Bezprozvanny I, Hayden MR, (2004) Deranged neuronal calcium signaling and Huntington disease. Biochem Biophys Res Commun 322(4):: 1310-1317. doi:10.1016/j.bbrc.2004.08.035. PubMed: 15336977.
6. Caviston JP, Holzbaur EL, (2009) Huntingtin as an essential integrator of intracellular vesicular trafficking. Trends Cell Biol 19(4):: 147-155. Epub 2009 Mar 5. doi:10.1016/j.tcb.2009.01.005. PubMed: 19269181.
7. Cisbani G, Cicchetti F, (2012) An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity. Cell Death Dis 3: e382. doi:10.1038/cddis.2012.121. PubMed: 22932724.
8. Trushina E, Dyer RB, Badger JD 2nd, Ure D, Eide L, et al. (2004) Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol 24(18):: 8195-8209. doi:10.1128/MCB.24.18.8195-8209.2004. PubMed: 15340079.
9. Zheng Z, Diamond MI, (2012) Huntington disease and the huntingtin protein. Prog Mol Biol. Transl Sci. 107: 189-214.
10. Di Maio L, Squitieri F, Napolitano G, Campanella G, Trofatter JA, et al. (1993) Onset symptoms in 510 patients with Huntington's disease. J Med Genet 30(4):: 289-292. doi:10.1136/jmg.30.4.289. PubMed: 8487272.
11. Myers RH, Sax DS, Schoenfeld M, Bird ED, Wolf PA, et al. (1985) Late onset of Huntington's disease. J Neurol Neurosurg, Psychiatry. 48(6):: 530-534. doi:10.1136/jnnp.48.6.530. PubMed: 3159849.
12. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 87(3):: 493-506. doi:10.1016/S0092-8674(00)81369-0. PubMed: 8898202.
13. Gray M, Shirasaki DI, Cepeda C, André VM, Wilburn B, et al. (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 28(24):: 6182-6195. doi:10.1523/JNEUROSCI.0857-08.2008. PubMed: 18550760.
14. Crook ZR, Housman D, (2011) Huntington's disease: can mice lead the way to treatment? Neuron. 69(3):: 423-435. doi:10.1016/j.neuron.2010.12.035. PubMed: 21315254.
15. Bowles KR, Brooks SP, Dunnett SB, Jones L, (2012) Gene expression and behaviour in mouse models of HD. Brain Res Bull 88(2-3):: 276-284. Epub 2011 Aug 10. doi:10.1016/j.brainresbull.2011.07.021. PubMed: 21854837.
16. Abada YS, Schreiber R, Ellenbroek B, (2013) Motor, emotional and cognitive deficits in adult BACHD mice: A model for Huntington's disease. Behav Brain Res 238: 243-251. doi:10.1016/j.bbr.2012.10.039. PubMed: 23123142. Epub 2012 Oct 30.
17. Kordasiewicz HB, Stanek LM, Wancewicz EV, Mazur C, McAlonis MM, et al. (2012) Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis. Neuron. 74(6):: 1031-1044. doi:10.1016/j.neuron.2012.05.009. PubMed: 22726834.
18. Menalled L, El-Khodor BF, Patry M, Suárez-Fariñas M, Orenstein SJ, et al. (2009) Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models. Neurobiol Dis 35(3):: 319-336. doi:10.1016/j.nbd.2009.05.007. PubMed: 19464370.
19. Pouladi MA, Stanek LM, Xie Y, Franciosi S, Southwell AL, et al. (2012) Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice. Hum Mol Genet 21(10):: 2219-2232. Epub 2012 Feb 9. doi:10.1093/hmg/dds037. PubMed: 22328089.
20. Southwell AL, Ko J, Patterson PH, (2009) Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease. J Neurosci 29(43):: 13589-13602. doi:10.1523/JNEUROSCI.4286-09.2009. PubMed: 19864571.
21. Tecott LH, Nestler EJ, (2004) Neurobehavioral assessment in the information age. Nat Neurosci 7(5):: 462-466. doi:10.1038/nn1225. PubMed: 15114359.
22. Yu-Taeger L, Petrasch-Parwez E, Osmand AP, Redensek A, Metzger S, et al. (2012) A Novel BACHD Transgenic Rat Exhibits Characteristic Neuropathological Features of Huntington Disease. J Neurosci 32(44):: 15426-15438. doi:10.1523/JNEUROSCI.1148-12.2012. PubMed: 23115180.
23. Hamers FP, Lankhorst AJ, van Laar TJ, Veldhuis WB, Gispen WH, (2001) Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries. J Neurotrauma. 18(2):: 187-201. doi:10.1089/08977150150502613. PubMed: 11229711.
24. Hamm RJ, Pike BR, O'Dell DM, Lyeth BG, Jenkins LW, (1994) The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. J Neurotrauma. 11(2):: 187-196. doi:10.1089/neu.1994.11.187. PubMed: 7932797.
25. Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, et al. (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 19(8):: 3248-3257. PubMed: 10191337.
26. Von Hörsten S, Schmitt I, Nguyen HP, Holzmann C, Schmidt T, et al. (2003) Transgenic rat model of Huntington's disease. Hum Mol Genet 12(6):: 617-624. doi:10.1093/hmg/ddg075. PubMed: 12620967.
27. Woodman B, Butler R, Landles C, Lupton MK, Tse J, et al. (2007) The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes. Brain Res Bull 72(2-3):: 83-97. doi:10.1016/j.brainresbull.2006.11.004. PubMed: 17352931.
28. Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, et al. (1995) Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg, Psychiatry. 58(2):: 192-200. doi:10.1136/jnnp.58.2.192. PubMed: 7876851.
29. Swerdlow NR, Caine SB, Geyer MA, (1992) Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology (Berl). 108(1-2):: 189-195. doi:10.1007/BF02245306. PubMed: 1410139.
30. Hahn-Barma V, Deweer B, Dürr A, Dodé C, Feingold J, et al. (1998) Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers. J Neurol Neurosurg, Psychiatry. 64(2):: 172-177. doi:10.1136/jnnp.64.2.172.
31. Lawrence AD, John RH, Anne ER, Ann K, Charles C, et al. (1998) Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 121: 1329-1341. doi:10.1093/brain/121.7.1329. PubMed: 9679784.
32. Rosenberg NK, Sørensen SA, Christensen AL, (1995) Neuropsychological characteristics of Huntington's disease carriers: a double blind study. J Med Genet 32(8):: 600-604. doi:10.1136/jmg.32.8.600. PubMed: 7473650.
33. Montoya A, Pelletier M, Menear M, Duplessis E, Richer F, et al. (2006) Episodic memory impairment in Huntington's disease: a meta-analysis. Neuropsychologia. 44(10):: 1984-1994. Epub 2006 Jun 23. doi:10.1016/j.neuropsychologia.2006.01.015. PubMed: 16797615.
34. Zeef DH, van Goethem NP, Vlamings R, Schaper F, Jahanshahi A, et al. (2012) Memory deficits in the transgenic rat model of Huntington's disease. Behav Brain Res 227(1):: 194-198. doi:10.1016/j.bbr.2011.11.009. PubMed: 22101303.
35. Chabot CC, Taylor DH, (1992) Circadian modulation of the rat acoustic startle response. Behav Neurosci 106(5):: 846-852. doi:10.1037/0735-7044.106.5.846. PubMed: 1445660.
36. Ellenbroek BA, de Bruin NM, van den Kroonenburg PT, van Luijtelaar EL, Cools AR, (2004) The effects of early maternal deprivation on auditory information processing in adult Wistar rats. Biol Psychiatry. 55(7):: 701-707. doi:10.1016/j.biopsych.2003.10.024. PubMed: 15038998.
37. Huntington G, (1972) On Chorea. The Medical and Surgical Reporter: A weekly Journal, (Philadelphia: S Butler) 26(15): 317-321.
38. Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, et al. (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12(13):: 1555-1567. doi:10.1093/hmg/ddg169. PubMed: 12812983.
39. Zeef DH, Vlamings R, Lim LW, Tan S, Janssen ML, et al. (2012) Motor and non-motor behaviour in experimental Huntington's disease. Behav Brain Res 226(2):: 435-439. Epub 2011 Oct 5. doi:10.1016/j.bbr.2011.09.041. PubMed: 22001615.
40. Paulsen JS, Ready RE, Hamilton JM, Mega MS, Cummings JL, (2001) Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg, Psychiatry. 71(3):: 310-314. doi:10.1136/jnnp.71.3.310. PubMed: 11511702.
41. Van Duijn E, Kingma EM, van der Mast RC, (2007) Psychopathology in verified Huntington's disease gene carriers. J Neuropsychiatry Clin Neurosci 19(4):: 441-448. doi:10.1176/appi.neuropsych.19.4.441. PubMed: 18070848.
42. Nguyen HP, Kobbe P, Rahne H, Wörpel T, Jäger B, et al. (2006) Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. Hum Mol Genet 15(21):: 3177-3194. Epub 2006 Sept 19. doi:10.1093/hmg/ddl394. PubMed: 16984963.
43. Koopmans GC, Deumens R, Brook G, Gerver J, Honig WM, et al. (2007) Strain and locomotor speed affect over-ground locomotion in intact rats. Physiol Behav 92(5):: 993-1001. Epub 2007 Aug 19. doi:10.1016/j.physbeh.2007.07.018. PubMed: 17959205.
44. Vandeputte C, Taymans JM, Casteels C, Coun F, Ni Y, et al. (2010) Automated quantitative gait analysis in animal models of movement disorders. BMC Neurosci 11: 92. doi:10.1186/1471-2202-11-92. PubMed: 20691122.
45. Pallier PN, Drew CJ, Morton AJ, (2009) The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor function. Brain Res Bull 78(6):: 347-355. Epub 2008 Nov 14. doi:10.1016/j.brainresbull.2008.10.007.PubMed: 19010400.
46. Koller WC, Trimble J, (1985) The gait abnormality of Huntington's disease. Neurology. 35(10):: 1450-1454. doi:10.1212/WNL.35.10.1450. PubMed: 3162109.
47. Brooks S, Fielding S, Döbrössy M, von Hörsten S, Dunnett S, (2009) Subtle but progressive cognitive deficits in the female tgHD hemizygote rat as demonstrated by operant SILT performance. Brain Res Bull 79(5):: 310-315. doi:10.1016/j.brainresbull.2009.03.003. PubMed: 19480990. Epub 2009 Mar 28.
48. Fink KD, Rossignol J, Crane AT, Davis KK, Bavar AM, et al. (2012) Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington's disease. Behav Neurosci 126(3):: 479-487. doi:10.1037/a0028028. PubMed: 22642889.
49. Kirch RD, Meyer PT, Geisler S, Braun F, Gehrig S, et al. (2013) Early deficits in declarative and procedural memory dependent behavioral function in a transgenic rat model of Huntington's disease. Behav Brain Res 239: 15-26. doi:10.1016/j.bbr.2012.10.048. PubMed: 23137697. Epub 2012 Nov 5.
50. Lawrence AD, Barbara JS, John RH, Anne ER, Klaus WL, et al. (1996) Executive and mnemonic functions in early Huntington's disease. Brain 119: 1633-1645. doi:10.1093/brain/119.5.1633. PubMed: 8931586.
51. Lawrence AD, Watkins LH, Sahakian BJ, Hodges JR, Robbins TW, (2000) Visual object and visuospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits. Brain. 123(7):: 1349-1364. doi:10.1093/brain/123.7.1349. PubMed: 10869048.
52. Van Raamsdonk JM, Pearson J, Slow EJ, Hossain SM, Leavitt BR, et al. (2005) Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J Neurosci 25(16):: 4169-4180. doi:10.1523/JNEUROSCI.0590-05.2005. PubMed: 15843620.
53. Kodsi MH, Swerdlow NR, (1997) Reduced prepulse inhibition after electrolytic lesions of nucleus accumbens subregions in the rat. Brain Res 773(1-2):: 45-52. doi:10.1016/S0006-8993(97)00869-X. PubMed: 9409703.
54. Seaman RL, (2000) Effects of acute systemic 3-nitropropionic acid administration on rat activity and acoustic startle. Neurosci Lett 280(3):: 183-186. doi:10.1016/S0304-3940(00)00790-4. PubMed: 10675791.
55. Castellanos FX, Fine EJ, Kaysen D, Marsh WL, Rapoport JL, et al. (1996) Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biol Psychiatry. 39(1):: 33-41. doi:10.1016/0006-3223(95)00101-8. PubMed: 8719124.
56. Esteban A, Mateo D, Giménez-Roldán S, (1981) Early detection of Huntington's disease. Blink reflex and levodopa load in presymptomatic and incipient subjects. J Neurol Neurosurg, Psychiatry. 44(1):: 43-48. doi:10.1136/jnnp.44.1.43.
57. Grillon C, Ameli R, Charney DS, Krystal J, Braff D, (1992) Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry. 32(10):: 939-943. doi:10.1016/0006-3223(92)90183-Z. PubMed: 1467378.
58. Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, et al. (2008) Towards a transgenic model of Huntington's disease in a non-human primate. Nature. 453(7197):: 921-924. Epub 2008 May 18. doi:10.1038/nature06975.PubMed: 18488016.